Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy

Glecaprevir (GLE)/pibrentasvir (PIB) is a pangenotypic direct-acting antiviral regimen approved for treating chronic hepatitis C virus. Primary treatment and re-treatment with GLE/PIB are effective and safe for patients without decompensated liver cirrhosis and chronic hepatitis C in a real-world cl...

Descripción completa

Detalles Bibliográficos
Autores principales: MASTROIANNI, ANTONIO, VANGELI, VALERIA, GRECO, SONIA, CHIDICHIMO, LUCIANA, URSO, FILIPPO, MAURO, MARIA VITTORIA, BONORA, STEFANO, DE NICOLÒ, AMEDEO, D’AVOLIO, ANTONIO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648555/
https://www.ncbi.nlm.nih.gov/pubmed/36415300
http://dx.doi.org/10.15167/2421-4248/jpmh2022.63.3.2137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648555/
https://www.ncbi.nlm.nih.gov/pubmed/36415300
http://dx.doi.org/10.15167/2421-4248/jpmh2022.63.3.2137

Ejemplares similares